U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H26N7O8P
Molecular Weight 583.4898
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FOSTEMSAVIR

SMILES

COC1=CN=C(N2C=NC(C)=N2)C3=C1C(=CN3COP(O)(O)=O)C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5

InChI

InChIKey=SWMDAPWAQQTBOG-UHFFFAOYSA-N
InChI=1S/C25H26N7O8P/c1-16-27-14-32(28-16)23-21-20(19(39-2)12-26-23)18(13-31(21)15-40-41(36,37)38)22(33)25(35)30-10-8-29(9-11-30)24(34)17-6-4-3-5-7-17/h3-7,12-14H,8-11,15H2,1-2H3,(H2,36,37,38)

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
FOSTEMSAVIR
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
fostemsavir [INN]
Common Name English
BMS-663068
Code English
Fostemsavir [WHO-DD]
Common Name English
(3-((4-BENZOYLPIPERAZIN-1-YL)-OXOACETYL)-4-METHOXY- 7-(3-METHYL-1H-1,2,4-TRIAZOL-1-YL)-1H-PYRROLO(2,3-C)PYRIDIN- 1-YL)METHYL DIHYDROGEN PHOSPHATE
Systematic Name English
FOSTEMSAVIR [MI]
Common Name English
FOSTEMSAVIR [USAN]
Common Name English
PIPERAZINE, 1-BENZOYL-4-((4-METHOXY-7-(3-METHYL-1H-1,2,4-TRIAZOL-1-YL)-1-((PHOSPHONOOXY)METHYL)-1H-PYRROLO(2,3-C)PYRIDIN-3-YL)OXOACETYL)-
Systematic Name English
BMS-663068 FREE ACID
Code English
Code System Code Type Description
USAN
AB-45
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
PUBCHEM
11319217
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
SMS_ID
100000169915
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
RXCUI
2380373
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
WIKIPEDIA
Fostemsavir
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
DRUG BANK
DB11796
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
ChEMBL
CHEMBL3301594
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
INN
10292
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
FDA UNII
97IQ273H4L
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
CAS
864953-29-7
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
EPA CompTox
DTXSID40235596
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
DAILYMED
97IQ273H4L
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
NCI_THESAURUS
C175066
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
MERCK INDEX
m12224
Created by admin on Sat Dec 16 01:35:02 UTC 2023 , Edited by admin on Sat Dec 16 01:35:02 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of TEMSAVIR
SALT/SOLVATE (PARENT)
Structure of FOSTEMSAVIR DISODIUM
SALT/SOLVATE (PARENT)
Structure of FOSTEMSAVIR DIHYDRATE
SALT/SOLVATE (PARENT)
Structure of FOSTEMSAVIR TROMETHAMINE
SUBSTANCE RECORD
Structure of FOSTEMSAVIR
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966